Scientific Presentations

Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All 2024 2023 2022 2021
11 Dec 2021
10:57 E.S.T.

Pre-clinical Development of a Highly Efficient TALEN®- ASH 2021- Poster Presentation

Download the PDF file
11 Dec 2021
10:55 E.S.T.

Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22- ASH 2021- Poster Presentation

Download the PDF file
12 Nov 2021
11:45 E.S.T.

Mesothelin (MSLN) Targeting Allogeneic CAR T Cells Engineedred to Overcome Tumor Immunosuppressive Microenvironment- SITC 2021- Poster Presentation

Download the PDF file
27 Oct 2021
09:15 E.S.T.

Preclinical development of a TALEN-based genome editing therapy for RAG1 deficiency - ESGCT 2021- Oral Presentation

Download the PDF file